- Home
- SGLY vs BDRX Comparison
SGLY vs BDRX Comparison
Compare SGLY & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$2.78
Company Overview
Basic Information| Metric | SGLY | BDRX |
|---|---|---|
| Founded | 2001 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 2.5M |
| IPO Year | 2008 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SGLY | BDRX |
|---|---|---|
| Price | $0.34 | $2.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 53.3K | 17.5K |
| Earning Date | 05-15-2026 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,813,193.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.34 | $0.60 |
| 52 Week High | $1.45 | $11.88 |
Technical Indicators
Market Signals| Indicator | SGLY | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.22 | 37.91 |
| Support Level | $0.34 | $2.22 |
| Resistance Level | $0.43 | $3.68 |
| Average True Range (ATR) | 0.02 | 0.24 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 8.76 | 12.30 |
Price Performance
Historical Comparison SGLY
BDRX
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.